Jolie Siegel

CIK 1768223 · Chief Legal Officer · last filed 2025-02-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$212.0K

Companies

2

Total Filings

21

Lifetime Open-Market Net

-$1.19M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CCCC Chief Legal Officer 54,353 $3.90 $212.0K -$1.19M 15 2025-02-18
Neon Therapeutics, Inc. (NTGN) Delisted VP, General Counsel 0 $0 6 2020-05-06

Recent Filings · Page 2 of 3

21 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-05-27 CCCC Exer (M) +3,750 $0 EDGAR
2022-02-16 CCCC Grant (A) $0 EDGAR
2021-09-14 CCCC Mixed -$562.8K EDGAR
2021-08-02 CCCC Mixed -$500.2K EDGAR
2021-02-16 CCCC Grant (A) $0 EDGAR
2020-05-06 Neon Therapeutics, Inc. (NTGN) Delisted Disp (D) −161,821 $0 EDGAR
2020-03-02 Neon Therapeutics, Inc. (NTGN) Delisted Tax (F) −2,845 -$4.3K EDGAR
2020-02-27 Neon Therapeutics, Inc. (NTGN) Delisted Tax (F) −5,334 -$8.1K EDGAR
2020-01-13 Neon Therapeutics, Inc. (NTGN) Delisted Grant (A) +65,000 $0 EDGAR
2019-11-25 Neon Therapeutics, Inc. (NTGN) Delisted Grant (A) +75,000 $0 EDGAR
Showing 1120 of 21
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.